Projects per year
Personal profile
Education
- 2010 Ph.D., National Cheng-Kung University, Taiwan
- 2004 M.S., Chang-Gung University, Taiwan
- 2002 B.S., Kaohsiung Medical University, Taiwan
Experience
- 2022- Professor, International Master Program in Medical Neuroscience, Taipei Medical University
- 2021- Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2020- Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2017-2020 Associate Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2013-2017 Assistant Professor,The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2011-2013 Postdoctoral Fellow, National Institute on Drug Abuse, NIH, U.S.A.
- 2010-2011 Postdoctoral Fellow, National Cheng-Kung University, Tainan, Taiwan
- 2009 Visiting Scholar, National Institute on Drug Abuse, NIH, , U.S.A
- 2004 Research Assistant, Chang-Gung University, Taiwan
Awards
- 2013 National Institutes of Health, Fellows Award for Research Excellence (FARE) 2013 winner
- 2010 National Cheng Kung University, Excellent Research Award
- 2009 The 17th International Symposium on Recent Advances in Cellular and Molecula Biology, Dr. Chien-Tien Hsu’ Award for Outstanding Dissertation
- 2008 National Cheng Kung University, Excellent Research Award
Research Interests
- Neuroprotection
- Brain cancer stem cell
- Drug addiction
Related Link
Fingerprint
Dive into the research topics where Jian-Ying Chuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
腦創傷後的神經再生研究(4/5)
2/1/23 → 1/31/24
Project: A - Government Institution › b - Ministry of Science and Technology
-
Investigating Nerve Regeneration Following Traumatic Brain Injury( III )
2/1/22 → 1/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
研究前列腺素E2介導的微膠細胞/巨噬細胞在膠質瘤進展中的作用
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
腦創傷後的神經再生研究(2/5)
2/1/21 → 1/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
HDAC6 藉由稳定膠質母细胞瘤中的雄激素受體表達來調節RAD51促進治療抗藥性發展
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects
Nepali, K., Wu, A. C., Lo, W. L., Chopra, B., Lai, M. J., Chuang, J. Y. & Liou, J. P., Feb 2023, In: European Journal of Medicinal Chemistry. 248, 115054.Research output: Contribution to journal › Article › peer-review
-
A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations
Ho, K. T., Chen, P. F., Chuang, J. Y., Gean, P. W. & Hsueh, Y. S., Jan 1 2022, In: Life Sciences. 288, 120176.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells
Chang, H. H., Chang, Y. Y., Tsai, B. C., Chen, L. J., Chang, A. C., Chuang, J. Y., Gean, P. W. & Hsueh, Y. S., Sept 2022, In: Cancers. 14, 18, 4537.Research output: Contribution to journal › Article › peer-review
Open Access -
Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation
Kuppusamy, R., Hsu, Y. T., Ke, Y. Y., Chang, P. W., Chang, Y. C., Chang, H. F., Wang, P. C., Lin, Y. H., Huang, Y. C., Yeh, T. K., Chuang, J. Y., Loh, H. H., Shih, C., Chen, C. T., Yeh, S. H. & Ueng, S. H., Dec 2022, In: European Journal of Medicinal Chemistry. 243, 114728.Research output: Contribution to journal › Article › peer-review
-
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells
Wu, A. C., Yang, W. B., Chang, K. Y., Lee, J. S., Liou, J. P., Su, R. Y., Cheng, S. M., Hwang, D. Y., Kikkawa, U., Hsu, T. I., Wang, C. Y., Chang, W. C., Chen, P. Y. & Chuang, J. Y., Dec 2022, In: Journal of Experimental and Clinical Cancer Research. 41, 1, 47.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)
Datasets
-
MOESM5 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Liu, J. (Creator), Chen, P. (Contributor), Chen, S. (Contributor), Chu, J. (Contributor), Chien, C. (Contributor), Yang, W. (Creator), Lo, W. (Creator), Hsu, T. (Contributor), Yang, K. (Creator), Chung, P. (Contributor), Chou, S. (Creator), Chang, K. (Contributor), Yang, S. (Creator), Chuang, J. (Creator), Huang, C. (Contributor) & Liu, M. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006868.v1, https://doi.org/10.6084%2Fm9.figshare.10006868.v1
Dataset
-
MOESM8 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chung, P. (Contributor), Chen, S. (Contributor), Hsu, T. (Contributor), Liu, M. (Creator), Lo, W. (Creator), Chu, J. (Contributor), Yang, K. (Creator), Yang, S. (Creator), Liu, J. (Creator), Chuang, J. (Creator), Yang, W. (Creator), Huang, C. (Contributor), Chien, C. (Contributor), Chang, K. (Contributor), Chen, P. (Contributor) & Chou, S. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006883.v1, https://doi.org/10.6084%2Fm9.figshare.10006883.v1
Dataset
-
Suberoylanilide hydroxamic acid represses glioma stem-like cells
Hsu, C. (Contributor), Chang, W. (Creator), Hsu, T. (Contributor), Liu, J. (Contributor), Yeh, S. (Contributor), Wang, J. (Creator), Liou, J. (Creator), Ko, C. (Contributor), Chang, K. (Creator) & Chuang, J. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3596465.v1, https://doi.org/10.6084%2Fm9.figshare.c.3596465.v1
Dataset
-
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chien, C. (Contributor), Chuang, J. (Creator), Yang, S. (Creator), Yang, W. (Creator), Chen, P. (Contributor), Hsu, T. (Contributor), Huang, C. (Contributor), Lo, W. (Creator), Yang, K. (Creator), Liu, M. (Creator), Chu, J. (Contributor), Chung, P. (Contributor), Liu, J. (Creator), Chou, S. (Creator), Chen, S. (Contributor) & Chang, K. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4705370.v1, https://doi.org/10.6084%2Fm9.figshare.c.4705370.v1
Dataset
-
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
Tsai, Y. (Creator), Lo, W. (Creator), Chen, P. (Creator), Ko, C. (Creator), Chuang, J. (Creator), Kao, T. (Creator), Yang, W. (Creator), Chang, K. (Creator), Hung, C. (Creator), Kikkawa, U. (Creator), Chang, W. (Creator) & Hsu, T. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5916320.v1, https://springernature.figshare.com/collections/Reprogramming_of_arachidonate_metabolism_confers_temozolomide_resistance_to_glioblastoma_through_enhancing_mitochondrial_activity_in_fatty_acid_oxidation/5916320/1
Dataset